Back to Directory Alicia Koblansky Email alicia.x.koblansky@viivhealthcare.com Phone 704-491-9495 Institution ViiV Healthcare Address ViiV Healthcare 410 Blackwell St. Suite 420 Durham, NC 27701 USA Request an Update Affiliated Studies IMPAACT 2023: A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1 DAIDS Number 38637 Research Area Therapeutics Study Status Enrolling
IMPAACT 2023: A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1 DAIDS Number 38637 Research Area Therapeutics Study Status Enrolling